There is evidence that DLGAP5 contributes to tumorigenesis and progression of numerous cancer types, for example, bladder cancer [34], endometrial cancer [35], ovarian cancer [36] and lung cancer [37, 38]. Here, DLGAP5 is linked to ovarian carcinoma.